Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis
about
Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical IssuesImproved Cardiovascular Disease Outcomes in Older AdultsEfficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial FibrillationChoosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to KnowEfficacy and safety of novel anticoagulants in the elderlyUse of Direct-Acting Oral Anticoagulants in Nonagenarians: A Call for More Data.Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.Geriatric Patient Safety Indicators Based on Linked Administrative Health Data to Assess Anticoagulant-Related Thromboembolic and Hemorrhagic Adverse Events in Older Inpatients: A Study Proposal.Individualising Anticoagulant Therapy in Atrial Fibrillation PatientsEvaluation of bleeding in patients receiving direct oral anticoagulants.Stroke in women - from evidence to inequalities.Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.Current challenges and future prospects in oral anticoagulant therapy.Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.Contemporary management of acute and chronic deep venous thrombosis.Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.Minimizing the Risk of Bleeding with NOACs in the Elderly.Use of novel oral anticoagulant agents in venous thromboembolism.Management of Atrial Fibrillation in Elderly Adults.Risk of gastrointestinal bleeding during anticoagulant treatment.Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation.Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate presPharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.Real-Life Peak and Trough Dabigatran Plasma Measurements over Time in Hospitalized Geriatric Patients with Atrial Fibrillation.Atrial fibrillation screening during automated blood pressure measurement-Comment on "Diagnostic accuracy of new algorithm to detect atrial fibrillation in a home blood pressure monitor".Anticoagulation Control in Swiss Primary Care: Time in Therapeutic Range Percentages Exceed Benchmarks of Phase III Trials.Cholesterol Crystal Embolism Induced by Direct Factor Xa Inhibitor: A First Case Report.[Anticoagulation in geriatric patients with atrial fibrillation : With what and for whom no more?]Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable.[New oral anticoagulants for prophylaxis of stroke. Results of an expert conference on practical use in geriatric patients].Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
P2860
Q26750767-BEEA0C35-3BD1-4A1C-B369-6FC30DE35F86Q26766094-3743DD6F-BDD9-45F6-85C2-A239C51531C7Q28071543-DA3CDA0E-3A6B-47B8-B194-52096AF07A03Q28074445-597FDAB6-026B-4935-AC54-5D15AFCA93D0Q28079383-3228B295-BCA7-489A-8BA9-988B8CC87540Q31066944-F655CC71-891D-45B1-8A34-B4C55C47E9F7Q33432917-7416FA0F-B1A5-49AD-A116-45125D83EFFAQ33729805-242071E5-7D18-42C3-A8BB-3C9BAE367EEBQ37235927-3492F141-A8D4-4E59-BA95-EF39B42AB330Q38598970-A6F3F1F4-AECB-48C2-83DA-1D18F0DBBC75Q38653864-CF6EBC24-5EB7-4CC9-A78B-15297779561CQ38653946-8CABBDD9-63BC-45F4-B3C1-68B5088A3589Q38675822-44358F02-1D24-4D12-82CF-592F012795A8Q38723869-954C6515-B3BC-4C3E-970D-54062A57D27BQ38740345-83754119-1F80-4C6A-B3AF-EA2CB712A2D9Q38776019-E650A0FB-24BF-4A26-BD68-27B3A426BD87Q38833382-3F48C55C-9B00-4F4F-A1FE-92E8E10D5A4AQ38998384-22B9B43C-BA04-4E8D-A622-40AE2B54F282Q39026788-513850A2-07FB-405D-A9E5-9B90B9609977Q39280394-C68AD226-0DF6-4DC1-AE15-DCACEE794F0EQ39359007-4AFDEA39-46FD-4287-88DE-B9601A199377Q39403789-C69C54E5-A02F-47C6-97A4-42C06B517CD4Q40242892-D81CC4CF-60C1-4C1B-8C78-1267D05DD84CQ40544536-73CEF4FD-4DF6-451B-AB3E-E4F714B16597Q40624080-7ECBD0BF-55FF-4A34-8E19-41C602F988C4Q42676634-52C41620-CDD5-45C0-BB84-97C440A4790FQ45974877-C9C4EED7-EC98-4CD5-9A29-1EAF206FE6A4Q47210396-615D79AF-9E91-4663-9D7F-A31436DC311BQ47676061-7FADD2A1-C162-46DE-B6AB-733E48BA831EQ47713063-8798B2AB-9435-4CBB-930D-368B1395AF94Q47930915-E10C74D8-09AC-4FAF-A7BD-4825C24368FFQ51771619-6A4EA680-0A38-447E-8C44-C8EF6355A376Q53513375-FAC75305-8D03-4586-A913-3C9F84C20415Q53635391-AB0EB6AD-9290-4C6B-BE96-3E69E56D2B5CQ58751103-DE83AF95-B5D3-413F-9E15-F9FC1CA86110
P2860
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@ast
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@en
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@nl
type
label
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@ast
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@en
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@nl
prefLabel
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@ast
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@en
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@nl
P2093
P2860
P31
P921
P3181
P1433
P1476
Efficacy and Harms of Direct O ...... matic Review and Meta-Analysis
@en
P2093
J Graham Davies
Jignesh P Patel
Manuj Sharma
Mariam Molokhia
P2860
P304
P3181
P356
10.1161/CIRCULATIONAHA.114.013267
P407
P577
2015-07-21T00:00:00Z